Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Beghi E, Giussani G, Abd-Allah F, Abdela J, Abdelalim A, Abraha HN, Adib MG, Agrawal S, Alandab F, Awasthi A, Ayele Y, et al. (2019)
LANCET NEUROLOGY 18(4): 357-375.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Abstract / Bemerkung
Background Seizures and their consequences contribute to the burden of epilepsy because they can cause health loss (premature mortality and residual disability). Data on the burden of epilepsy are needed for health-care planning and resource allocation. The aim of this study was to quantify health loss due to epilepsy by age, sex, year, and location using data from the Global Burden of Diseases, Injuries, and Risk Factors Study. Methods We assessed the burden of epilepsy in 195 countries and territories from 1990 to 2016. Burden was measured as deaths, prevalence, and disability-adjusted life-years (DALYs; a summary measure of health loss defined by the sum of years of life lost [YLLs] for premature mortality and years lived with disability), by age, sex, year, location, and Socio-demographic Index (SDI; a compound measure of income per capita, education, and fertility). Vital registrations and verbal autopsies provided information about deaths, and data on the prevalence and severity of epilepsy largely came from population representative surveys. All estimates were calculated with 95% uncertainty intervals (UIs). Findings In 2016, there were 45.9 million (95% UI 39. 9-54 .6) patients with all-active epilepsy (both idiopathic and secondary epilepsy globally; age-standardised prevalence 621.5 per 100 000 population; 540.1-737.0). Of these patients, 24.0 million (20.4-27.7) had active idiopathic epilepsy (prevalence 3 26 7 per 100 000 population; 278.4-378.1). Prevalence of active epilepsy increased with age, with peaks at 5-9 years (374.8 [280 .1-490 .0]) and at older than 80 years of age (545.1 [444. 2-652. 0]). Age-standardised prevalence of active idiopathic epilepsy was 329.3 per 100 000 population (280.3-381. 2) in men and 318.9 per 100 000 population (271.1-369.4) in women, and was similar among SDI quintiles. Global age-standardised mortality rates of idiopathic epilepsy were 1.74 per 100 000 population (1.64-1.87; 1.40 per 100 000 population [1. 23-1.54] for women and 2.09 per 100 000 population [1.96-2.25] for men). Age-standardised DALYs were 182.6 per 100 000 population (149. 0-223 .5; 163.6 per 100 000 population [130.6-204.3] for women and 201.2 per 100 000 population [166. 9-241. 4] for men). The higher DALY rates in men were due to higher YLL rates compared with women. Between 1990 and 2016, there was a non-significant 6.0% (-4.0 to 16.7) change in the age-standardised prevalence of idiopathic epilepsy, but a significant decrease in age-standardised mortality rates (24.5% [10.8 to 31.8]) and age-standardised DALY rates (19.4% [9.0 to 27.6]). A third of the difference in age-standardised DALY rates between low and high SDI quintile countries was due to the greater severity of epilepsy in low-income settings, and two-thirds were due to a higher YLL rate in low SDI countries. Interpretation Despite the decrease in the disease burden from 1990 to 2016, epilepsy is still an important cause of disability and mortality. Standardised collection of data on epilepsy in population representative surveys will strengthen the estimates, particularly in countries for which we currently have no or sparse data and if additional data is collected on severity, causes, and treatment. Sizeable gains in reducing the burden of epilepsy might be expected from improved access to existing treatments in low-income countries and from the development of new effective drugs worldwide. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.
Erscheinungsjahr
Zeitschriftentitel
LANCET NEUROLOGY
Band
18
Ausgabe
4
Seite(n)
357-375
ISSN
eISSN
PUB-ID

Zitieren

Beghi E, Giussani G, Abd-Allah F, et al. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. LANCET NEUROLOGY. 2019;18(4):357-375.
Beghi, E., Giussani, G., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H. N., Adib, M. G., et al. (2019). Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. LANCET NEUROLOGY, 18(4), 357-375. doi:10.1016/S1474-4422(18)30454-X
Beghi, E., Giussani, G., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H. N., Adib, M. G., Agrawal, S., Alandab, F., Awasthi, A., et al. (2019). Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. LANCET NEUROLOGY 18, 357-375.
Beghi, E., et al., 2019. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. LANCET NEUROLOGY, 18(4), p 357-375.
E. Beghi, et al., “Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016”, LANCET NEUROLOGY, vol. 18, 2019, pp. 357-375.
Beghi, E., Giussani, G., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H.N., Adib, M.G., Agrawal, S., Alandab, F., Awasthi, A., Ayele, Y., Barboza, M.A., Belachew, A.B., Biadgo, B., Bijani, A., Bitew, H., Carvalho, F., Chaiah, Y., Daryani, A., Huyen Phuc Do, H.P.D., Dubey, M., Endries, A.Y.Y., Eskandarieh, S., Faro, A., Farzadfar, F., Fereshtehnejad, S.-M., Fernandes, E., Fijabi, D.O., Filip, I., Fischer, F., Gebre, A.K., Tsadik, A.G., Gebremichael, T.G., Gezae, K.E., Ghasemi-Kasman, M., Weldegwergs, K.G., Degefa, M.G., Gnedovskaya, Elena, V., Hagos, T.B., Haj-Mirzaian, A., Haj-Mirzaian, A., Hassen, H.Y., Hay, Simon, I., Jakovljevic, M., Kasaeian, A., Kassa, T.D., Khader, Y.S., Khalil, I., Khan, E.A., Khubchandani, J., Kisa, A., Krohn, K.J., Kulkarni, C., Nirayo, Y.L., Mackay, M.T., Majdan, M., Majeed, A., Manhertz, T., Mehndiratta, M.M., Mekonen, T., Meles, H.G., Mengistu, G., Mohammed, S., Naghavi, M., Mokdad, A.H., Mustafa, G., Irvani, S.S.N., Long Hoang Nguyen, L.H.N., Nichols, E., Nixon, M.R., Ogbo, F.A., Olagunju, A.T., Olagunju, T.O., Owolabi, M.O., Philips, M.R., Pinilla-Monsalve, G.D., Qorbani, M., Radfar, A., Rafay, A., Rahimi-Movaghar, V., Reinig, N., Sachdev, P.S., Safari, H., Safari, S., Safiri, S., Sahraian, M.A., Samy, A.M., Sarvi, S., Sawhney, M., Shaikh, M.A., Sharif, M., Singh, G., Smith, M., Szoeke, Cassandra E., I., Tabares-Seisdedos, R., Temsah, M.-H., Temsah, O., Tortajada-Girbes, M., Bach Xuan Tran, B.X.T., Tsegay, A.A.T., Ullah, I., Venketasubramanian, N., Westerman, R., Winkler, A.S., Yimer, E.M., Yonemoto, N., Feigin, V.L., Vos, T., Murray, C.J.L.: Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. LANCET NEUROLOGY. 18, 357-375 (2019).
Beghi, Ettore, Giussani, Giorgia, Abd-Allah, Foad, Abdela, Jemal, Abdelalim, Ahmed, Abraha, Haftom Niguse, Adib, Mina G., Agrawal, Sutapa, Alandab, Fares, Awasthi, Ashish, Ayele, Yohanes, Barboza, Miguel A., Belachew, Abate Bekele, Biadgo, Belete, Bijani, Ali, Bitew, Helen, Carvalho, Felix, Chaiah, Yazan, Daryani, Ahmad, Huyen Phuc Do, Huyen Phuc Do, Dubey, Manisha, Endries, Aman Yesuf Yesuf, Eskandarieh, Sharareh, Faro, Andre, Farzadfar, Farshad, Fereshtehnejad, Seyed-Mohammad, Fernandes, Eduarda, Fijabi, Daniel Obadare, Filip, Irina, Fischer, Florian, Gebre, Abadi Kahsu, Tsadik, Afewerki Gebremeskel, Gebremichael, Teklu Gebrehiwo, Gezae, Kebede Embaye, Ghasemi-Kasman, Maryam, Weldegwergs, Kidu Gidey, Degefa, Meaza Girma, Gnedovskaya, Elena, V, Hagos, Tekleberhan B., Haj-Mirzaian, Arvin, Haj-Mirzaian, Arya, Hassen, Hamid Yimam, Hay, Simon, I, Jakovljevic, Mihajlo, Kasaeian, Amir, Kassa, Tesfaye Dessale, Khader, Yousef Saleh, Khalil, Ibrahim, Khan, Ejaz Ahmad, Khubchandani, Jagdish, Kisa, Adnan, Krohn, Kristopher J., Kulkarni, Chanda, Nirayo, Yirga Legesse, Mackay, Mark T., Majdan, Marek, Majeed, Azeem, Manhertz, Treh, Mehndiratta, Man Mohan, Mekonen, Tesfa, Meles, Hagazi Gebre, Mengistu, Getnet, Mohammed, Shafiu, Naghavi, Mohsen, Mokdad, Ali H., Mustafa, Ghulam, Irvani, Seyed Sina Naghibi, Long Hoang Nguyen, Long Hoang Nguyen, Nichols, Emma, Nixon, Molly R., Ogbo, Felix Akpojene, Olagunju, Andrew T., Olagunju, Tinuke O., Owolabi, Mayowa Ojo, Philips, Michael R., Pinilla-Monsalve, Gabriel David, Qorbani, Mostafa, Radfar, Amir, Rafay, Anwar, Rahimi-Movaghar, Vafa, Reinig, Nickolas, Sachdev, Perminder S., Safari, Hosein, Safari, Saeed, Safiri, Saeid, Sahraian, Mohammad Ali, Samy, Abdallah M., Sarvi, Shahabeddin, Sawhney, Monika, Shaikh, Masood A., Sharif, Mehdi, Singh, Gagandeep, Smith, Mari, Szoeke, Cassandra E., I, Tabares-Seisdedos, Rafael, Temsah, Mohamad-Hani, Temsah, Omar, Tortajada-Girbes, Miguel, Bach Xuan Tran, Bach Xuan Tran, Tsegay, Amanuel Amanuel Tesfay, Ullah, Irfan, Venketasubramanian, Narayanaswamy, Westerman, Ronny, Winkler, Andrea Sylvia, Yimer, Ebrahim M., Yonemoto, Naohiro, Feigin, Valery L., Vos, Theo, and Murray, Christopher J. L. “Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016”. LANCET NEUROLOGY 18.4 (2019): 357-375.

1 Zitation in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

37 References

Daten bereitgestellt von Europe PubMed Central.

The epidemiology of the epilepsies.
Neligan A, Hauser WA, Sander JW., Handb Clin Neurol 107(), 2012
PMID: 22938966
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology.
Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshe SL, Peltola J, Roulet Perez E, Scheffer IE, Zuberi SM., Epilepsia 58(4), 2017
PMID: 28276060
Epilepsy in poor regions of the world.
Newton CR, Garcia HH., Lancet 380(9848), 2012
PMID: 23021288
The natural history and prognosis of epilepsy.
Beghi E, Giussani G, Sander JW., Epileptic Disord 17(3), 2015
PMID: 26234761

AUTHOR UNKNOWN, 2006
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.
Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, Pringsheim T, Lorenzetti DL, Jette N., Neurology 88(3), 2016
PMID: 27986877
Estimation of the burden of active and life-time epilepsy: a meta-analytic approach.
Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR., Epilepsia 51(5), 2010
PMID: 20067507
Incidence of epilepsy: a systematic review and meta-analysis
Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR., 2016
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
GBD 2015 Neurological Disorders Collaborator Group, Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, Abyu GY, Ahmed MB, Aichour AN, Aichour I, Aichour MTE, Akinyemi RO, Alabed S, Al-Raddadi R, Alvis-Guzman N, Amare AT, Ansari H, Anwari P, Arnlov J, Asayesh H, Asgedom SW, Atey TM, Avila-Burgos L, Frinel E, Avokpaho GA, Azarpazhooh MR, Barac A, Barboza M, Barker-Collo SL, Barnighausen T, Bedi N, Beghi E, Bennett DA, Bensenor IM, Berhane A, Betsu BD, Bhaumik S, Birlik SM, Biryukov S, Boneya DJ, Bulto LNB, Carabin H, Casey D, Castaneda-Orjuela CA, Catala-Lopez F, Chen H, Chitheer AA, Chowdhury R, Christensen H, Dandona L, Dandona R, de Veber GA, Dharmaratne SD, Do HP, Dokova K, Dorsey ER, Ellenbogen RG, Eskandarieh S, Farvid MS, Fereshtehnejad SM, Fischer F, Foreman KJ, Geleijnse JM, Gillum RF, Giussani G, Goldberg EM, Gona PN, Goulart AC, Gugnani HC, Gupta R, Hachinski V, Gupta R, Hamadeh RR, Hambisa M, Hankey GJ, Hareri HA, Havmoeller R, Hay SI, Heydarpour P, Hotez PJ, Jakovljevic MMB, Javanbakht M, Jeemon P, Jonas JB, Kalkonde Y, Kandel A, Karch A, Kasaeian A, Kastor A, Keiyoro PN, Khader YS, Khalil IA, Khan EA, Khang YH, Tawfih A, Khoja A, Khubchandani J, Kulkarni C, Kim D, Kim YJ, Kivimaki M, Kokubo Y, Kosen S, Kravchenko M, Krishnamurthi RV, Defo BK, Kumar GA, Kumar R, Kyu HH, Larsson A, Lavados PM, Li Y, Liang X, Liben ML, Lo WD, Logroscino G, Lotufo PA, Loy CT, Mackay MT, El Razek HMA, El Razek MMA, Majeed A, Malekzadeh R, Manhertz T, Mantovani LG, Massano J, Mazidi M, McAlinden C, Mehata S, Mehndiratta MM, Memish ZA, Mendoza W, Mengistie MA, Mensah GA, Meretoja A, Mezgebe HB, Miller TR, Mishra SR, Ibrahim NM, Mohammadi A, Mohammed KE, Mohammed S, Mokdad AH, Moradi-Lakeh M, Velasquez IM, Musa KI, Naghavi M, Ngunjiri JW, Nguyen CT, Nguyen G, Le Nguyen Q, Nguyen TH, Nichols E, Ningrum DNA, Nong VM, Norrving B, Noubiap JJN, Ogbo FA, Owolabi MO, Pandian JD, Parmar PG, Pereira DM, Petzold M, Phillips MR, Piradov MA, Poulton RG, Pourmalek F, Qorbani M, Rafay A, Rahman M, Rahman MH, Rai RK, Rajsic S, Ranta A, Rawaf S, Renzaho AMN, Rezai MS, Roth GA, Roshandel G, Rubagotti E, Sachdev P, Safiri S, Sahathevan R, Sahraian MA, Samy AM, Santalucia P, Santos IS, Sartorius B, Satpathy M, Sawhney M, Saylan MI, Sepanlou SG, Shaikh MA, Shakir R, Shamsizadeh M, Sheth KN, Shigematsu M, Shoman H, Silva DAS, Smith M, Sobngwi E, Sposato LA, Stanaway JD, Stein DJ, Steiner TJ, Stovner LJ, Abdulkader RS, Ei Szoeke C, Tabares-Seisdedos R, Tanne D, Theadom AM, Thrift AG, Tirschwell DL, Topor-Madry R, Tran BX, Truelsen T, Tuem KB, Ukwaja KN, Uthman OA, Varakin YY, Vasankari T, Venketasubramanian N, Vlassov VV, Wadilo F, Wakayo T, Wallin MT, Weiderpass E, Westerman R, Wijeratne T, Wiysonge CS, Woldu MA, Wolfe CDA, Xavier D, Xu G, Yano Y, Yimam HH, Yonemoto N, Yu C, Zaidi Z, El Sayed Zaki M, Zunt JR, Murray CJL, Vos T., Lancet Neurol 16(11), 2017
PMID: 28931491
Neurocysticercosis as the main cause of late-onset epilepsy in Mexico.
Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J., Arch. Intern. Med. 150(2), 1990
PMID: 2302008
Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador.
Del Brutto OH, Santibanez R, Idrovo L, Rodriguez S, Diaz-Calderon E, Navas C, Gilman RH, Cuesta F, Mosquera A, Gonzalez AE, Tsang VC, Garcia HH., Epilepsia 46(4), 2005
PMID: 15816956
Vascular determinants of epilepsy: the Rotterdam Study.
Li X, Breteler MM, de Bruyne MC, Meinardi H, Hauser WA, Hofman A., Epilepsia 38(11), 1997
PMID: 9579923
Alcohol consumption, unprovoked seizures, and epilepsy: a systematic review and meta-analysis.
Samokhvalov AV, Irving H, Mohapatra S, Rehm J., Epilepsia 51(7), 2010
PMID: 20074233
Standards for epidemiologic studies and surveillance of epilepsy.
Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D, Hesdorffer DC, Hauser WA, Kazis L, Kobau R, Kroner B, Labiner D, Liow K, Logroscino G, Medina MT, Newton CR, Parko K, Paschal A, Preux PM, Sander JW, Selassie A, Theodore W, Tomson T, Wiebe S; ILAE Commission on Epidemiology., Epilepsia 52 Suppl 7(), 2011
PMID: 21899536
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.
Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshe SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM., Epilepsia 58(4), 2017
PMID: 28276062
Disability weights for the Global Burden of Disease 2013 study.
Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar M, Speybroeck N, Murray CJ, Vos T., Lancet Glob Health 3(11), 2015
PMID: 26475018
Epilepsy misconceptions and stigma reduction interventions in sub-Saharan Africa, a systematic review.
Kaddumukasa M, Kaddumukasa MN, Buwembo W, Munabi IG, Blixen C, Lhatoo S, Sewankambo N, Katabira E, Sajatovic M., Epilepsy Behav 85(), 2018
PMID: 29906697
Assessing the disease burden due to epilepsy by disability adjusted life year in rural China.
Ding D, Hong Z, Wang WZ, Wu JZ, de Boer HM, Prilipko L, Sander JW., Epilepsia 47(12), 2006
PMID: 17201700
Epidemiology of epilepsy and its burden in Kolkata, India.
Banerjee TK, Dutta S, Ray BK, Ghosal M, Hazra A, Chaudhuri A, Das SK., Acta Neurol. Scand. 132(3), 2015
PMID: 25689886
Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil.
Noronha AL, Borges MA, Marques LH, Zanetta DM, Fernandes PT, de Boer H, Espindola J, Miranda CT, Prilipko L, Bell GS, Sander JW, Li LM., Epilepsia 48(5), 2007
PMID: 17326788
Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England.
Heaney DC, MacDonald BK, Everitt A, Stevenson S, Leonardi GS, Wilkinson P, Sander JW., BMJ 325(7371), 2002
PMID: 12411362
Socioeconomic status is a risk factor for epilepsy in Icelandic adults but not in children.
Hesdorffer DC, Tian H, Anand K, Hauser WA, Ludvigsson P, Olafsson E, Kjartansson O., Epilepsia 46(8), 2005
PMID: 16060943
Incidence and prevalence of treated epilepsy among poor health and low-income Americans.
Kaiboriboon K, Bakaki PM, Lhatoo SD, Koroukian S., Neurology 80(21), 2013
PMID: 23616158
Prevalence of epilepsy--an unknown quantity.
Beghi E, Hesdorffer D., Epilepsia 55(7), 2014
PMID: 24966095
The epidemiology of the comorbidity of epilepsy in the general population.
Gaitatzis A, Carroll K, Majeed A, W Sander J., Epilepsia 45(12), 2004
PMID: 15571520
Risk for injuries and accidents in epilepsy: A prospective population-based cohort study.
Mahler B, Carlsson S, Andersson T, Tomson T., Neurology 90(9), 2018
PMID: 29386275
ILAE official report: a practical clinical definition of epilepsy.
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA, Glynn M, Hesdorffer DC, Lee BI, Mathern GW, Moshe SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S., Epilepsia 55(4), 2014
PMID: 24730690

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 30773428
PubMed | Europe PMC

Suchen in

Google Scholar